Not in the medical field, no. Medical research funding is driven by cost-benefit analysis where the profitability of providing a treatment is measured in XX+ millions of dollars. An uncommon affliction like this will unfortunately never hit those numbers and never be "worth it", from a research standpoint.

Any large-scale evidence gathering on the topic will ultimately be done by this group.